Please assess the completion status of the following clinical trial:

Trial Title: Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Treatment naive PCOS women having age from 14-45 years with scanty or no menstruation, hirsutism and elevated serum androgen levels, will be diagnosed on the basis of AES (Androgen access society) guidelines 2006 according to which when two of the following criteria are present patient will be said to have the syndrome~2. Hirsutism or hyperandrogenism~3. Oligo or an-ovulation and or polycystic ovaries -~Exclusion Criteria:~1. Women with previous history of Cushing syndrome~2. Thyroid disorders~3. Hyperprolactinemia~4. Ovarian tumors~5. Congenital adrenal hyperplasia androgen-producing tumors,~6. History of seizures~7. Patients on warfarin, Coumadin and Sintrom because of drug interaction with acetyl-L-Carnitine,~8. Pregnancy or using contraceptive medications,~9. Patients on hormonal therapy that alters the biochemical or hormonal profile

- Gender: FEMALE
- Minimum Age: 15 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Combination therapy group (Type: ACTIVE_COMPARATOR): Arm 1: Metformin (1000 mg daily), Pioglitazone (30 mg daily), Acetyl-L-carnitine (3 gm daily)
- Standard therapy group (Type: PLACEBO_COMPARATOR): Arm 2: Metformin (1000 mg daily), Pioglitazone (30 mg daily), Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).